Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer.

about

Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer.

Item

http://www.wikidata.org/entity/Q55292718

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@en

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@nl

type

Item

label

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@en

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@nl

prefLabel

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@en

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@nl

P1476

Lipid Accumulation in Peripher ...... in Patients with Lung Cancer.

@en

P2093

Akihiro Takemasa

http://www.w3.org/2001/XMLSchema#string

Fumito Ohmi

http://www.w3.org/2001/XMLSchema#string

Hiroko Morita

http://www.w3.org/2001/XMLSchema#string

Ryo Arai

http://www.w3.org/2001/XMLSchema#string

Sayo Soda

http://www.w3.org/2001/XMLSchema#string

Tomoe Funakoshi

http://www.w3.org/2001/XMLSchema#string

Tomoko Okutomi

http://www.w3.org/2001/XMLSchema#string

P2860

Lipid accumulation and dendritic cell dysfunction in cancer

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells.

Analysis and testing of biological stains--the Biological Stain Commission Procedures.

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape

Mouse and human dendritic cell subtypes.

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

Mechanisms and functional significance of tumour-induced dendritic-cell defects.

P304

5708239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/5708239

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Yoshiki Ishii

P577

2018-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29850632

http://www.w3.org/2001/XMLSchema#string

P932

5925181

http://www.w3.org/2001/XMLSchema#string